XBiotech Inc. (XBIT)

XBiotech Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	125.55	172.68	200.02	157.31	236.98
Short-Term Investments	-	-	-	60.17	-
Cash & Short-Term Investments	125.55	172.68	200.02	217.48	236.98
Cash Growth	-27.29%	-13.67%	-8.03%	-8.23%	-0.16%
Other Receivables	0.36	0.86	0.94	1.76	8.95
Total Trade Receivables	0.36	0.86	0.94	1.76	8.95
Other Current Assets	1.04	1.03	0.76	0.6	0.93
Total Current Assets	126.95	174.57	201.72	219.84	246.87
Net Property, Plant & Equipment	23.13	24.53	24.9	26.26	28.31
Total Assets	150.08	199.09	226.62	246.1	275.18
Accounts Payable	1.54	2.22	2.52	2.41	2.07
Accrued Expenses	6.32	2.63	3.5	1.6	1.37
Short-Term Debt	-	10.25	-	-	-
Other Current Liabilities	0.08	-	0.08	0.06	0.01
Total Current Liabilities	7.93	15.11	6.1	4.07	3.45
Other Long-Term Liabilities	1.8	1.72	1.67	1.64	2.34
Total Long-Term Liabilities	1.8	1.72	1.67	1.64	2.34
Total Liabilities	9.73	16.83	7.77	5.7	5.79
Common Stock	276.73	273.11	271.15	267.33	262.26
Accumulated Other Comprehensive Income	-	-	-	0.83	1.97
Retained Earnings	-136.38	-90.84	-52.31	-27.75	5.15
Shareholders' Equity	140.35	182.27	218.85	240.4	269.39
Total Liabilities & Equity	150.08	199.09	226.62	246.1	275.18
Total Debt	0	10.25	0	0	0
Net Cash (Debt)	125.55	162.43	200.02	217.48	236.98
Net Cash Growth	-22.70%	-18.80%	-8.03%	-8.23%	-0.16%
Net Cash Per Share	4.12	5.33	6.57	5.72	7.89
Book Value	140.35	182.27	218.85	240.4	269.39
Book Value Per Share	4.60	5.98	7.19	6.33	8.97
Tangible Book Value	140.35	182.27	218.85	240.4	269.39
Tangible Book Value Per Share	4.60	5.98	7.19	6.33	8.97

Updated Mar 13, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q